Approval · Notice of Compliance 26862 · 2021
CEPHALEXIN: Notice of Compliance 26862
Issued October 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26862
- Date
- October 18, 2021
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Licensing Agreement Between Two Companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEPHALEXIN | 02521253 | Marketed |
| CEPHALEXIN | 02521261 | Marketed |
Medicinal ingredients
- CEPHALEXIN MONOHYDRATE 250 MG per TAB
- CEPHALEXIN MONOHYDRATE 500 MG per TAB